Verywell Health on MSN

What to Know About Symbicort (Budesonide and Formoterol)

Medically reviewed by Sanja Jelic, MD Key Takeaways Symbicort is an inhaler used for long-term control of asthma and COPD, but it is not a rescue inhaler.Before using Symbicort, tell your healthcare ...
Monthly Prescribing Reference

FDA Approves Inhaler Monitoring Device for Symbicort

The SmartTouch for Symbicort is a monitoring device that is installed onto the patient's inhaler to track and improve medication adherence. The Food and Drug Administration (FDA) has granted Adherium ...
FiercePharma

Long-Term Study Demonstrates Safety and Efficacy of SYMBICORT® in African American Patients with Asthma

DENVER--(BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) today announced results from a long-term study comparing SYMBICORT ® (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol 160/4.5 mcg with ...
Business Wire

US FDA Updates SYMBICORT Label with LABA Safety Class Revisions and Removes Boxed WARNING for Serious Asthma-Related Outcomes

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved updates to the SYMBICORT ® (budesonide ...
Monthly Prescribing Reference

Digital Health Tool Propeller Cleared for Use With Symbicort Inhaler

The Food and Drug Administration (FDA) has cleared the Propeller Health digital platform to connect with the Symbicort® Inhaler (budesonide, formoterol fumarate dihydrate; AstraZeneca), a ...
EurekAlert!

Study analyzed SYMBICORT in children with persistent asthma

Wilmington, DE – May 20, 2008 – A new 12-week study2examined safety and efficacy measures of the maintenance combination asthma therapy, SYMBICORT® (budesonide ...
MedPage Today on MSN

Triple Therapy Inhaler Improves Lung Function in Poorly Controlled Asthma

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta ...
Healthline

Symbicort Side Effects and Tips for Managing Them

Symbicort, which is used to treat chronic obstructive pulmonary disease and asthma, can cause side effects. Mild side effects include nasal congestion and headaches. Serious side effects include ...
Nasdaq

AstraZeneca's Symbicort Granted Pediatric Exclusivity by FDA

AstraZenecaAZN announced that the FDA has granted six months of pediatric exclusivity to its Symbicort inhalation aerosol. Symbicort is a combination formulation containing budesonide, an inhaled ...
FierceBiotech

Press Release: AstraZeneca Announces Symbicort Is Now Available In The U.S.

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...
EurekAlert!

AstraZeneca submits an sNDA for Symbicort for treatment of asthma in children as young as 6

Wilmington, DE – June 4, 2008 – AstraZeneca (NYSE: AZN) today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

UK industry body finds AstraZeneca in breach of code over Symbicort marketing

AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...